What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Heart failure
- Cardiology
Mihai Gheorghiade mainly focuses on Heart failure, Internal medicine, Cardiology, Heart disease and Intensive care medicine.
Mihai Gheorghiade works on Heart failure which deals in particular with Ejection fraction.
In his study, Severity of illness is strongly linked to Surgery, which falls under the umbrella field of Internal medicine.
His work on Randomization expands to the thematically related Cardiology.
His work carried out in the field of Heart disease brings together such families of science as Dobutamine, Mortality rate, Circulatory system, Disease and Etiology.
His research integrates issues of Guideline, Epidemiology, MEDLINE and Emergency medicine in his study of Intensive care medicine.
His most cited work include:
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) (3995 citations)
- The effect of digoxin on mortality and morbidity in patients with heart failure (1936 citations)
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 (1542 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Heart failure, Internal medicine, Cardiology, Intensive care medicine and Ejection fraction.
In general Heart failure, his work in Tolvaptan is often linked to In patient linking many areas of study.
His biological study spans a wide range of topics, including Placebo and Surgery.
The Cardiology study combines topics in areas such as Prospective cohort study and Blood pressure.
His Intensive care medicine study incorporates themes from Epidemiology, MEDLINE, Drug development, Emergency medicine and Disease.
His Ejection fraction study frequently draws parallels with other fields, such as Pulmonary wedge pressure.
He most often published in these fields:
- Heart failure (83.97%)
- Internal medicine (70.03%)
- Cardiology (60.39%)
What were the highlights of his more recent work (between 2013-2021)?
- Heart failure (83.97%)
- Internal medicine (70.03%)
- Cardiology (60.39%)
In recent papers he was focusing on the following fields of study:
His main research concerns Heart failure, Internal medicine, Cardiology, Intensive care medicine and Ejection fraction.
His Heart failure study frequently involves adjacent topics like Clinical trial.
His research investigates the connection between Internal medicine and topics such as Placebo that intersect with problems in Aliskiren.
His Cardiology research is multidisciplinary, incorporating perspectives in Diabetes mellitus, Tolerability, Interquartile range and Clinical endpoint.
His Intensive care medicine study also includes
- Drug development which connect with Cardiovascular agent,
- Diuretic and related Hemoconcentration.
His Ejection fraction study incorporates themes from Prospective cohort study, Surgery, Quality of life, Blood pressure and Myocardial infarction.
Between 2013 and 2021, his most popular works were:
- The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. (1015 citations)
- Phenomapping for novel classification of heart failure with preserved ejection fraction. (457 citations)
- Expert consensus document: Mitochondrial function as a therapeutic target in heart failure (251 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Heart failure
- Disease
Mihai Gheorghiade spends much of his time researching Heart failure, Internal medicine, Cardiology, Ejection fraction and Intensive care medicine.
His Heart failure research incorporates themes from Diabetes mellitus, Interquartile range and Clinical trial.
His biological study deals with issues like Placebo, which deal with fields such as Randomized controlled trial.
His Cardiology research integrates issues from Disease progression, Tolerability, Proportional hazards model and Cohort study.
His Ejection fraction research incorporates elements of Coronary artery disease, Surgery, Myocardial infarction and Atrial fibrillation.
He combines subjects such as Endocrinology, Kidney disease, Cardiovascular agent and Comorbidity with his study of Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
